Subscribe To
abbvie, exelon, and more stocks for the recession that may—or may not—be coming
Going to cash ignores the fact that inflation is eroding the value of money as we speak. Another option: Buy the stocks that have historically perform...
April 1, 2022, 7:36 pm
Is most-watched stock abbvie inc. (abbv) worth betting on now?
Recently, Zacks.com users have been paying close attention to abbvie (ABBV). This makes it worthwhile t...
March 31, 2022, 10:32 am
abbvie stock is up 20% ytd: is it out of juice now?
abbvie Inc (NYSE: ABBV) is already up about 20% for the year but Boston Private's Shannon Saccocia cont...
March 23, 2022, 4:17 pm
What's in store for abbvie this year? #askhalftime
The "Halftime Report" traders answer your questions in #AskHalftime...
March 23, 2022, 2:07 pm
Is abbvie stock a buy now?
The drugmaker's business looks as healthy as ever....
March 22, 2022, 7:36 am
abbvie (abbv) gains but lags market: what you should know
abbvie (ABBV) closed the most recent trading day at $156.05, moving +0.11% from the previous trading se...
March 16, 2022, 6:48 pm
abbvie (abbv) inks deal to develop covid antiviral treatment
abbvie (ABBV) joins Scripps Research in the latter's SARS-CoV-2 research program to accelerate the deve...
March 16, 2022, 12:47 pm
abbvie: no longer a one trick pony
abbvie has been a one trick pony that relied heavily on a single drug, Humira, in the past. However, ma...
March 14, 2022, 2:03 pm
abbvie (abbv) inks deal for neuropsychiatric conditions
abbvie (ABBV) forges an alliance with Gedeon Richter to develop novel treatments for neuropsychiatric d...
March 14, 2022, 12:02 pm
abbvie's (abbv) qulipta meets chronic migraine study endpoints
abbvie's (ABBV) new oral anti-CGRP drug, Qulipta, demonstrates potential to reduce monthly migraine day...
March 11, 2022, 12:48 pm
What's in store for these 3 big pharma outperformers in 2022?
J&J (JNJ), abbvie (ABBV) and Merck (MRK) are three large drugmakers that have outperformed the industry...
March 9, 2022, 10:32 am
Genmab (gmab), abbvie lymphoma candidate gets orphan drug tag
Genmab (GMAB) and abbvie are co-developing epcoritamab as a potential treatment for non-Hodgkin's lymph...
March 9, 2022, 10:32 am
Blockbusters from bristol-myers, abbvie losing exclusivity
Of the $17 billion in annual sales that will be lost to copycat drugs this year, a Bristol-Myers Squibb Co. ( BMY , Financial) cancer medication is in...
March 8, 2022, 4:19 pm
abbvie, inc. (abbv) presents at cowen health care broker conference call - (transcript)
abbvie, Inc. (ABBV) Presents at Cowen Health Care Broker Conference Call - (Transcript)...
March 8, 2022, 4:03 pm
abbvie inc.: hunker down and hedge up with its 3.8% dividend
Global financial markets are going through extreme volatilities, with the market fluctuating more than 2% and the VIX index exceeding its 95% percenti...
March 8, 2022, 11:38 am
abbvie acquisition strengthens its neuroscience portfolio
The structure of abbvie Inc.‘s ( ABBV , Financial) buyout of a clinical-stage biotechnology company t...
March 3, 2022, 5:50 pm
abbvie acquisition strengthens its neuroscience portfolio
The structure of abbvie Inc.‘s ( ABBV , Financial) buyout of a clinical-stage biotechnology company t...
March 3, 2022, 5:50 pm
abbvie acquisition strengthens its neuroscience portfolio
The structure of abbvie Inc.‘s ( ABBV , Financial) buyout of a clinical-stage biotechnology company t...
March 3, 2022, 5:50 pm
Is this dividend king a buy for 2022 and beyond?
abbvie offers investors a market-beating dividend yield even as it trades near its all-time high....
March 3, 2022, 10:53 am